These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18271834)

  • 1. Health-related quality of life in the era of erythropoietin.
    Weisbord SD; Kimmel PL
    Hemodial Int; 2008 Jan; 12(1):6-15. PubMed ID: 18271834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis.
    Evans RW
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):62-70. PubMed ID: 1928082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of health-related quality of life among patients with chronic kidney disease.
    Unruh ML; Hess R
    Adv Chronic Kidney Dis; 2007 Oct; 14(4):345-52. PubMed ID: 17904501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with end-stage renal disease treated with hemodialysis: survival is not enough!
    Kimmel PL; Cohen SD; Weisbord SD
    J Nephrol; 2008; 21 Suppl 13():S54-8. PubMed ID: 18446733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms and their correlates in chronic kidney disease.
    Weisbord SD
    Adv Chronic Kidney Dis; 2007 Oct; 14(4):319-27. PubMed ID: 17904498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study Group.
    Laupacis A
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):11-9. PubMed ID: 2192412
    [No Abstract]   [Full Text] [Related]  

  • 8. The quality of life of dialysis patients treated with recombinant human erythropoietin.
    Auer J; Oliver DO; Winearls CG
    Scand J Urol Nephrol Suppl; 1990; 131():61-5. PubMed ID: 2075472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life, treatment efficacy, and hemodialysis patient outcome.
    Simic-Ogrizovic S; Jemcov T; Pejanovic S; Stosovic M; Radovic M; Djukanovic L
    Ren Fail; 2009; 31(3):201-6. PubMed ID: 19288325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in nephrology research and clinical practice.
    Unruh ML; Weisbord SD; Kimmel PL
    Semin Dial; 2005; 18(2):82-90. PubMed ID: 15771650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life for children with chronic kidney disease.
    Goldstein SL; Gerson AC; Goldman CW; Furth S
    Semin Nephrol; 2006 Mar; 26(2):114-7. PubMed ID: 16530604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of recombinant erythropoietin on the quality of life in patients over 60 years of age undergoing hemodialysis].
    Russo GE; Giusti S; Vitaliano E; Caramiello MS; Maurici M; De Marco CM; Pennacchia M; D'Auria F; Bonello M; Bruno C; Marigliano V
    Clin Ter; 1997 Mar; 148(3):89-93. PubMed ID: 9377845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of end-stage renal disease patients and study on the implementation of nocturnal home hemodialysis in Greece.
    Stavrianou K; Pallikarakis N
    Hemodial Int; 2007 Apr; 11(2):204-9. PubMed ID: 17403172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Review of quality of life instruments used in end-stage renal disease].
    Gentile S; Delarozière JCh; Fernandez C; Tardieu S; Devictor B; Dussol B; Daurès JP; Berland Y; Sambuc R
    Nephrologie; 2003; 24(6):293-301. PubMed ID: 14584296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory variables associated with quality of life in Brazilian haemodialysis patients: a single-centre study.
    Santos PR; Franco Sansigolo Kerr LR
    Rev Med Chil; 2008 Oct; 136(10):1264-71. PubMed ID: 19194622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis.
    Kimmel PL; Patel SS
    Semin Nephrol; 2006 Jan; 26(1):68-79. PubMed ID: 16412831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life assessment in clinical practice.
    Meers C; Singer MA
    J CANNT; 1996; 6(2):29-31. PubMed ID: 8900807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in end-stage renal disease patients: the effects of renal rehabilitation.
    Kouidi E
    Clin Nephrol; 2004 May; 61 Suppl 1():S60-71. PubMed ID: 15233250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.